Market Overview:
The global iridoid compound market is expected to grow at a CAGR of 6.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for iridoid compounds from the pharmaceutical and health product industries. Additionally, the growing awareness about the benefits of iridoid compounds is also contributing to the growth of this market. On the basis of type, natural iridoids are expected to dominate this market during the forecast period owing to their high demand from various end-use industries. On account of their therapeutic properties, these compounds are being increasingly used in drugs and health products. Synthetic iridoids are also witnessing a high demand due their enhanced properties as compared with natural counterparts.
Product Definition:
An iridoid compound is a type of organic compound that includes a cyclopentane ring fused to a six-membered lactone ring. These compounds are found in plants and have various biological activities, including anti-inflammatory and analgesic effects.
Natural:
Natural is a chemical compound derived from carbon compounds and hydrogen. Natural products are obtained from plant materials, animal excreta, or mineral sources. The most commonly known natural product is sugar (from which ethanol also can be derived). Other important natural products include starch, cellulose, vegetable oils & fats (such as cholesterol), minerals (such as calcium & iron), and water.
Synthesis:
Synthesis is the process of making a particular substance or compound. In this process, various raw materials are used in combination to produce a finished product. Synthesis is majorly used for producing pharmaceutical drugs and industrial chemicals. Synthetic products are usually made by chemical synthesis, which involves the conversion of raw materials into pure form using an efficient procedure called synthetic procedure or synthesis.
Application Insights:
Drug application dominated the global iridoid compound market in 2017, accounting for over 60% of the overall revenue share. The segment is expected to witness significant growth during the forecast period owing to extensive usage of iridoids as drugs, such as felbamate and gabapentin.
The health products segment is also anticipated to witness considerable growth during the forecast period due to increasing use of iridoids in dietary supplements and over-the-counter medicines globally. For instance, it has been used traditionally for various ailments such as anxiety and stress relief worldwide.
Regional Analysis:
North America dominated the global iridoid compound market in 2017. The growth can be attributed to the presence of a large number of companies engaged in drug discovery and development. In addition, increasing R&D activities by various organizations is expected to fuel regional market growth over the forecast period. For instance, recently, Sohn Conference & Visitors Bureau organized a two-day conference on medicinal chemistry that was focused on current trends and developments related to drug discovery using natural products from plants and fungi.
Asia Pacific is anticipated to witness lucrative CAGR during the forecast period owing to rising healthcare expenditure coupled with growing awareness regarding bio-based economy in emerging countries such as China and India. Moreover, high demand for new pharmaceuticals due to rapid economic development will drive regional market growth over the next eight years (2018 - 2030).
Growth Factors:
- Increasing demand for natural and organic products
- Rising awareness about the health benefits of iridoid compounds
- Growing popularity of herbal supplements and remedies
- Proliferation of online retail channels
- Emerging applications for iridoid compounds in cosmetics, nutraceuticals, and pharmaceuticals
Scope Of The Report
Report Attributes
Report Details
Report Title
Iridoid Compound Market Research Report
By Type
Natural, Synthesis
By Application
Drugs, Health Products, Others
By Companies
Enzo Life Sciences, Sigma-Aldrich, LKT Labs
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
245
Number of Tables & Figures
172
Customization Available
Yes, the report can be customized as per your need.
Global Iridoid Compound Market Report Segments:
The global Iridoid Compound market is segmented on the basis of:
Types
Natural, Synthesis
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Drugs, Health Products, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Enzo Life Sciences
- Sigma-Aldrich
- LKT Labs
Highlights of The Iridoid Compound Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Natural
- Synthesis
- By Application:
- Drugs
- Health Products
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Iridoid Compound Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Iridoid compound is a type of natural supplement that has been used in traditional Chinese medicine for centuries. Iridoid compounds are thought to help improve overall health by supporting the body's immune system and regulating blood sugar levels.
Some of the major companies in the iridoid compound market are Enzo Life Sciences, Sigma-Aldrich, LKT Labs.
The iridoid compound market is expected to register a CAGR of 6.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Iridoid Compound Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Iridoid Compound Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Iridoid Compound Market - Supply Chain
4.5. Global Iridoid Compound Market Forecast
4.5.1. Iridoid Compound Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Iridoid Compound Market Size (000 Units) and Y-o-Y Growth
4.5.3. Iridoid Compound Market Absolute $ Opportunity
5. Global Iridoid Compound Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Iridoid Compound Market Size and Volume Forecast by Type
5.3.1. Natural
5.3.2. Synthesis
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Iridoid Compound Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Iridoid Compound Market Size and Volume Forecast by Application
6.3.1. Drugs
6.3.2. Health Products
6.3.3. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Iridoid Compound Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Iridoid Compound Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Iridoid Compound Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Iridoid Compound Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Iridoid Compound Demand Share Forecast, 2019-2026
9. North America Iridoid Compound Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Iridoid Compound Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Iridoid Compound Market Size and Volume Forecast by Application
9.4.1. Drugs
9.4.2. Health Products
9.4.3. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Iridoid Compound Market Size and Volume Forecast by Type
9.7.1. Natural
9.7.2. Synthesis
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Iridoid Compound Demand Share Forecast, 2019-2026
10. Latin America Iridoid Compound Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Iridoid Compound Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Iridoid Compound Market Size and Volume Forecast by Application
10.4.1. Drugs
10.4.2. Health Products
10.4.3. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Iridoid Compound Market Size and Volume Forecast by Type
10.7.1. Natural
10.7.2. Synthesis
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Iridoid Compound Demand Share Forecast, 2019-2026
11. Europe Iridoid Compound Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Iridoid Compound Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Iridoid Compound Market Size and Volume Forecast by Application
11.4.1. Drugs
11.4.2. Health Products
11.4.3. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Iridoid Compound Market Size and Volume Forecast by Type
11.7.1. Natural
11.7.2. Synthesis
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Anaysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Iridoid Compound Demand Share, 2019-2026
12. Asia Pacific Iridoid Compound Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Iridoid Compound Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Iridoid Compound Market Size and Volume Forecast by Application
12.4.1. Drugs
12.4.2. Health Products
12.4.3. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Iridoid Compound Market Size and Volume Forecast by Type
12.7.1. Natural
12.7.2. Synthesis
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Iridoid Compound Demand Share, 2019-2026
13. Middle East & Africa Iridoid Compound Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Iridoid Compound Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Iridoid Compound Market Size and Volume Forecast by Application
13.4.1. Drugs
13.4.2. Health Products
13.4.3. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Iridoid Compound Market Size and Volume Forecast by Type
13.7.1. Natural
13.7.2. Synthesis
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Iridoid Compound Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Iridoid Compound Market: Market Share Analysis
14.2. Iridoid Compound Distributors and Customers
14.3. Iridoid Compound Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Enzo Life Sciences
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Sigma-Aldrich
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. LKT Labs
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. COMPANY4
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. COMPANY5
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. COMPANY6
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
